Like AlphaImpactRx, Inc

closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via BusinessWire

Xcenda, acquired Dymaxium, Inc.

synopsis: Xcenda, a part of AmerisourceBergen, announced the acquisition of Dymaxium, a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
buyer parent: AmerisourceBergen Corporation
buyer: Xcenda
Xcenda, part of AmerisourceBergen, is a strategic consultancy with 20+ years of experience applying real-world expertise in health economics and outcomes research, reimbursement, stakeholder insights, and market access consulting and communications. "
target: Dymaxium, Inc.
Dymaxium is a trusted market access partner specializing in the exchange of evidence and information between payers and life science companies through its FormularyDecisions.com® platform.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/7/2016 via BNC Analysis

M3, Inc., will acquire Vidal Group

synopsis: Electra Partners’ portfolio company AXIO Group has received a binding offer from M3 Inc. to purchase Vidal Group, a European provider of reference drug information. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients with on-line access to up-to-date drug databases and related treatment-based information.
buyer: M3, Inc. (TSE:2413:$1,127.03)
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet. "
target parent: Electra Partners LLP
target: Vidal Group
Vidal Group is a leading European healthcare informatics and information systems company. Vidal Group provides hospitals, primary care physicians, pharmacists, and patients across Europe with on-line access to up-to-date drug databases and related treatment-based information.
price ($mm)
$133
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Affinity Equity Partners, will acquire MedicalDirector

synopsis: Leading Asian private equity firm Affinity Equity Partners agreed to acquire Sydney-based MedicalDirector (formerly Health Communication Network) from Australia’s Primary Health Care Ltd. MedicalDirector is a leading provider of clinical and enterprise software solutions to general practitioners, medical specialists and allied health professionals.
buyer: Affinity Equity Partners
Affinity Equity Partners is an independently-owned buyout fund manager comprising primarily the former investment professionals of UBS Capital Asia Pacific. They are pioneers in buyout investments in the Asia-Pacific region, with an established and widely recognised franchise. "
target parent: Primary Health Care Limited
target: MedicalDirector
MedicalDirector has been supporting healthcare professionals and improving health outcomes for more than 20 years. They provide software for practice management, optimizing patient outcomes, and access to Australia's most comprehensive and up-to-date pharmaceutical database.
price ($mm)
$119
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/26/2015 via Company Press Release

Inovalon, Inc., will acquire Avalere Health LLC

synopsis: Inovalon, a leading technology company providing cloud-based analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
buyer: Inovalon, Inc. (INOV:$449.36)
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. "
target: Avalere Health LLC
Avalere Health, Inc. is a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.
price ($mm)
$140
rev ($mm)
$47
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 6/11/2012 via BNC Analysis

Piramal Healthcare Limited, acquired Decision Resources Group

synopsis: Piramal Healthcare Limited has completed its previously announced acquisition of Decision Resources Group, a US based company in the healthcare information segment. Decision Resources Group is a cohesive portfolio of companies that offers best in class, high-value information and insights on important sectors of the healthcare industry.
buyer parent: Piramal Group
buyer: Piramal Healthcare Limited
With assets across North America, Europe and Asia, Piramal Healthcare is one of the largest pharmaceutical custom manufacturing companies across the world. It has significant presence in the global critical care space with sales of anesthesia products to over 100 countries. "
target parent: Providence Equity Partners Inc.
target: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions.
price ($mm)
$635
rev ($mm)
$160
EBITDA ($mm)
EV / rev
4.0x
EV / EBITDA
closed 7/22/2010 via Company Press Release

CT Corsearch, acquired Edital

synopsis: CT Corsearch, the premier provider of clearance and protection solutions for trademark and brand professionals, announced it’s acquired Edital, the Questel trademark branch. This acquisition will create best-in-class solutions for managing a brand lifecycle globally—from creation to watching to protecting, maintaining and renewing a brand.
buyer parent: Wolters Kluwer NV
buyer: CT Corsearch
CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes. "
target parent: Questel
target: Edital
Edital was established in Brussels in 1982 and acquired by Questel, a world leader in Intellectual Property in 2005. Its sole purpose has been to create global solutions for the Intellectual Property professional.
price ($mm)
rev ($mm)
$8
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 9/27/2007 via PR Newswire

Thomson Pharma, acquired Prous Science

synopsis: The Thomson Corporation, a leading provider of information solutions to business and professional customers worldwide, today announced that it has acquired Prous Science, a global leader in the provision of life sciences information solutions. Prous Science will become part of Thomson Scientific.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Prous Science
Prous Science is a trusted source of information on which science depends to discover safer and more effective medicines. The company's products have evolved through the years from print journals to sophisticated electronic products incorporating the latest advances in IT.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2007 via Company Description

MergerMarket, acquired Infinata, Inc.

synopsis: In September 2007, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
buyer parent: Pearson plc
buyer: MergerMarket
MergerMarket, part of Pearson's Financial Times Group, is an unparalleled, independent M&A intelligence tool used by the world's foremost financial institutions to originate deals. It provides proprietary intelligence on potential deal flow, potential mandates and valuations. "
target: Infinata, Inc.
Infinata is an innovative provider of information solutions and marketing analytics to the global financial service, life science, and high-tech industries. Our information suites include: BioPharm Insight, High Net Worth Insight, and Corporate Tracker.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/28/2020 via Company Press Release

JMDC Inc., will acquire MeCompany

synopsis: JMDC Inc., a company that provides medical data statistics, life insurance data statistics, health data platform management, and other services, will be acquiring MeCompany, a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database.
buyer: JMDC Inc. (TSE:4483:$91.75)
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan. "
target: MeCompany
Based in Japan, MeCompany is a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database. MeCompany strives to develop a matching service that creates encounters between medical institutions and pharmacies and patients
price ($mm)
$9.76
rev ($mm)
$2
EBITDA ($mm)
EV / rev
4.4x
EV / EBITDA
announced 10/7/2019 via BNC Analysis

Inflexion Private Equity Partners LLP, will acquire Pharmaspectra

synopsis: Inflexion Private Equity, a UK mid-market private equity firm, will acquire Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature.
buyer: Inflexion Private Equity Partners LLP
Inflexion is a UK mid-market private equity firm. They invest in high growth, entrepreneurial businesses and work with them to accelerate growth. Inflexion’s flexible approach allows it to back both majority and minority investments, typically investing £10m to £150m of equity in each deal. "
target: Pharmaspectra
Pharmaspectra is a global provider of medical affairs data to the pharmaceutical and biotech industry. Pharmaspectra offers the world's largest database for medical scientific literature and biomedical literature. Their web-based solutions analyze data across the entire medical continuum.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$216.82)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2014 via BusinessWire

Fitzroy Health, acquired RJ Health Systems

synopsis: Fitzroy Health, LLC announced the acquisition of RJ Health Systems International, LLC. RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
buyer: Fitzroy Health
Fitzroy Health is an investment and management firm that helps high potential healthcare companies reach scale by investing capital, managing execution, and developing commercialization and expansion strategies. "
target: RJ Health Systems
RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/3/2013 via Company Press Release

JISC Collections, acquired SpringerProtocols

synopsis: Springer announced that JISC Collections has purchased the archive content of SpringerProtocols; the world’s largest database of life sciences protocols. SpringerProtocols contains more than 31,000 protocols, most of which come from the classic book series “Methods in Molecular Biology”.
buyer: JISC Collections
JISC Collections supports the procurement of digital content for education and research in the UK. They are uniquely placed to provide members with: expertise in negotiating and procurement, within the scholarly communications sector. "
target parent: EQT
target: SpringerProtocols
SpringerProtocols combines the world’s largest collection of life sciences and bio-medicine protocols with advanced search functionality. Used primarily in the life sciences, the protocols provide sets of instructions that allow scientists to recreate experiments in their own laboratories.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2013 via BNC Analysis

Optum, acquired Humedica

synopsis: Optum has acquired Humedica. Humedica is the clinical intelligence company that powers health care providers, life sciences and research organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
buyer parent: UnitedHealth Group
buyer: Optum
Optum, through its subsidiaries, provides information and technology-enabled health services. It offers health management solutions that address the physical, mental, and financial needs of individuals and organizations. "
target: Humedica
Humedica is the clinical intelligence company that powers health care providers and life sciences organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2012 via BNC Analysis

TechCapital Group, acquired iHealthEcon

synopsis: TechCapital Group, Life Science Unit has acquired iHealthEcon, a health economics solutions company that helps life sciences organizations plan, develop and advocate health economics to global payers through e-registry-suite.
buyer: TechCapital Group
Established in 1992, TechCapital Group is a private global investment firm that originates, structures and acts as lead equity investor in equity private placements. The R&D management consulting unit provides decision support tools to advanced scientific based engineering groups. "
target: iHealthEcon
iHealthEcon, through e-registry, offers its clients an innovative suite of decision support tools to advance market access by improving the speed and efficiency of collecting health economics and outcomes research registry data in real time to National Health Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/29/2014 via BusinessWire

Booz Allen Hamilton Inc., acquired Epidemico

synopsis: Booz Allen Hamilton announced that it has acquired Epidemico, Inc., a move that underscores the firm’s commitment to further develop analytic capabilities areas such as population health. Epidemico is an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health.
buyer parent: Carlyle Group
buyer: Booz Allen Hamilton Inc. (BAH:$6,366.88)
Booz Allen Hamilton Inc. provides professional services primarily to US government agencies in the defense, security, and civil sectors, as well as to corporations, institutions, and not-for-profit organizations. The company provides a range of services in strategy, operations, and more. "
target: Epidemico
Epidemico is an informatics company established in 2007 that provides early insights, continuous monitoring and consumer engagement for a wide range of population health domains, including disease outbreaks, drug safety, supply chain vulnerabilities and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/23/2012 via BusinessWire

ImpactRx, Inc., acquired AlphaDetail, Inc.

synopsis: ImpactRx, a Symphony Technology Group company, and the pioneer in measuring the impact of promotion on physicians’ attitudes and prescribing behavior, announced that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: AlphaDetail, Inc.
AlphaDetail is a rapidly growing global market research consulting company focused on the pharmaceutical and biotechnology industry. It uses the Internet as a channel to enable rapid, convenient, and effective communication between pharmaceutical companies, healthcare professionals and patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via BusinessWire

IMS Health Incorporated, acquired Privacy Analytics

synopsis: IMS Health has acquired Privacy Analytics Incorporated. Privacy Analytics offers an innovative suite of data governance software and advisory services that enable stakeholders to optimize benefits of the growing volume and availability of new, complex datasets while protecting patient privacy.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. "
target: Privacy Analytics
Privacy Analytics enables healthcare organizations to quickly and easily apply a risk-based responsible de-identification methodology that ensures individual privacy and legal compliance. They offer expert training, software, methodology and services that protect the privacy of individuals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2016 via BusinessWire

IMS Health Incorporated, acquired Dimensions Healthcare, LLC

synopsis: IMS Health, a leading global provider of information and technology services to the healthcare and life sciences industries, announced completion of its acquisition of Dimensions Healthcare, a United Arab Emirates (UAE) company which provides high quality healthcare systems to payers, providers and regulatory bodies.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Dimensions Healthcare, LLC
Dimensions Healthcare (“Dimensions”) is a leading developer of healthcare informatics solutions that assist private and public sectors to offer higher-quality healthcare services by collecting and processing information that is used to decrease inefficiencies and reduce wasteful expenditures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2015 via BNC Analysis

IMS Health Incorporated, acquired IASIST, S.A.

synopsis: IMS Health, a leading global information and technology services company, has acquired IASIST, an added value, professional service company which offers health care providers, payers and the health industry the clinical and economic information required to improve quality and efficiency in their organizations.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: IASIST, S.A.
Iasist is an added value, professional service company which offers health care providers, payers and the health industry the clinical and economic information required to improve quality and efficiency in their organisations and the services provided to their customers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2015 via BusinessWire

IMS Health Incorporated, purchased CRM and Strategic Data Division from Cegedim

synopsis: IMS Health, a leading global provider of information and technology services to the healthcare and life sciences industries, completed its acquisition of certain customer relationship management (CRM) and strategic data businesses of Cegedim, a global technology and services company specializing in healthcare.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. The company connects complex healthcare data on diseases, treatments, costs and outcomes. "
seller: Cegedim (ENXTPA:CGM:$512.82)
Cegedim is a global technology and services company specializing in healthcare. Cegedim’s CRM solutions help Life Sciences and Healthcare clients in 80 countries drive sales effectiveness, optimize marketing programs across multiple channels and mitigate regulatory compliance risks.
price ($mm)
$523
rev ($mm)
$584
EBITDA ($mm)
$88
EV / rev
0.9x
EV / EBITDA
5.9x
closed 5/8/2014 via BusinessWire

IMS Health Incorporated, acquired Forcea

synopsis: IMS Health has acquired Forcea, a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Forcea
Forcea is a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2013 via BusinessWire

IMS Health Incorporated, acquired Pygargus

synopsis: IMS Health, a leading worldwide provider of information, technology and services, has acquired Pygargus, an industry-leading life sciences advisory and analytics firm based in Sweden, to further advance its technology-enabled Real-World Evidence solutions and global RWE footprint.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Pygargus
Pygargus is a leading independent Scandinavian life science consultancy specialized in Real World Outcomes Research, offering expertise in electronic medical records, registry data handling, data integration and scientific project management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/15/2013 via BNC Analysis

IMS Health Incorporated, will acquire Diversinet Corp.

synopsis: Toronto-based mobile health company Diversinet agreed to sell its assets to subsidiaries of Parsippany, New Jersey-based IMS Health for about $3.5 million. The sale includes Diversinet’s intellectual property, software, and customer contracts. IMS Health is a leading worldwide provider of healthcare information, technology, and services.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Diversinet Corp. (US:DVNTF:$1.51)
Diversinet provides its customers and partners with ultra-secure, patented mobile technologies and connected health solutions. Its core multilingual publishing platform supports rapid deployment of secure and HIPAA-compliant Web-to-mobile applications.
price ($mm)
$1.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2013 via BusinessWire

IMS Health Incorporated, acquired Incential Software, Inc.

synopsis: IMS Health has acquired Incential Software, an industry-leading Software-as-a-Service company based in Raleigh, NC, to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers technology & services that integrate incentive compensation, data management, & business intelligence applications.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Incential Software, Inc.
Incential Software is a leading provider of sales performance management software and services to pharmaceutical, biotech and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2013 via BusinessWire

IMS Health Incorporated, acquired 360 Vantage

synopsis: IMS Health announced the acquisition of 360 Vantage, a leading provider of cloud-based multi-channel CRM and closed loop marketing technologies, to further extend its commercial Software-as-a-Service capabilities for life sciences and healthcare organizations around the globe.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: 360 Vantage
Established in 2005 and headquartered in Chandler, Arizona, 360 Vantage is a leader in cloud-based mobile sales and marketing systems designed to solve the more complex front office challenges in Life Sciences and Healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/30/2013 via BusinessWire

IMS Health Incorporated, acquired Semantelli

synopsis: IMS Health announced the acquisition of Semantelli Corporation, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer engagement capabilities for healthcare organizations around the world. Semantelli offers cloud-based tools that automate the collection of healthcare-specific social media content.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Semantelli
Semantelli’s solutions for global life sciences and healthcare companies address compliance needs in social media, guide marketing activities and identify new real-time opportunities with insights gleaned from social media.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/12/2013 via Yahoo, Inc.

IMS Health Incorporated, acquired Appature

synopsis: IMS Health has acquired Appature, a leading Software-as-a-Service (SaaS) company based in Seattle. Appature offers clients a cloud-based relationship marketing platform to address the complexities of today’s multi-stakeholder healthcare environment, and to enable the measurement and optimization of relationship marketing programs across channels.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Ignition Partners
target: Appature
Appature is a Seattle-based technology company that provides cloud-based marketing solutions designed exclusively for healthcare companies. Leaders in the pharmaceutical, medical device, and health and wellness industries rely on Appature to realize the true potential of their marketing efforts
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2012 via BusinessWire

IMS Health Incorporated, acquired PharmaDeals Ltd.

synopsis: IMS Health announced the acquisition of PharmaDeals Ltd., a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global pharmaceutical industry. PharmaDeals maintains a web-based subscription database containing more than 46,000 records of industry transactions.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: PharmaVentures Ltd.
target: PharmaDeals Ltd.
PharmaDeals Ltd. is a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/5/2010 via Company Press Release

CPP Investment Board, TPG Capital, acquired IMS Health Incorporated

synopsis: IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, announced the completion of its acquisition by entities created by certain affiliates of TPG Capital, L.P. (“TPG”) and the CPP Investment Board (“CPPIB”).
buyer: CPP Investment Board
buyer: TPG Capital
TPG is a leading global private investment firm with approximately $45 billion of capital under management across a family of funds. TPG's investment philosophy has been to create value by investing in change - change created by industry trends, economic cycles or specific company circumstances. "
target: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations.
price ($mm)[EV]
$4,014 [$5,057]
rev ($mm)
$2,171
EBITDA ($mm)
$489
EV / rev
2.3x
EV / EBITDA
10.4x
announced 7/7/2008 via PR Newswire

Signalife, Inc., will acquire Heart One Global Research

synopsis: Signalife, Inc. and Heart One Global Research, an Irish-based heart information and clinical information management concern -- with technology used across the world through subsidiaries and affiliates in eight different countries have agreed to merge or consummate a similar business combination making them one company.
buyer: Signalife, Inc. (SGN:$0.00)
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. "
target: Heart One Global Research
Heart One Global is the London-based international developer and distributor of information technologies that are clinically focused, mature, stable, robust, comprehensive, flexible, portable, and standards-based electronic health record solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via BusinessWire

Elsevier Business Information, acquired Clinical Practice Model Resource Center, Inc.

synopsis: Elsevier, the world's leading publisher of science and health information, has purchased CPM Resource Center from Eclipsys, a leading provider of integrated enterprise clinical, revenue cycle, access management, and decision support solutions. CPM Resource Center is a leading provider of executable evidence-based clinical tools.
buyer parent: Reed Elsevier plc
buyer: Elsevier Business Information
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year. "
target parent: Eclipsys Corporation
target: Clinical Practice Model Resource Center, Inc.
CPM Resource Center’s evidence-based products and professional services assist healthcare organizations in creating a healthy work culture and interdisciplinary integration using a professional practice framework and standardization.
price ($mm)
$25
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via BusinessWire

Healthnostics, Inc., acquired MedNets, Inc.

synopsis: Healthnostics, Inc. a medical and biotechnology analytics company, today announced the completion of the MedNets.com acquisition, an Internet portal providing healthcare information resources to consumers and professionals.
buyer: Healthnostics, Inc. (OTCPK:HNSS:$0.20)
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information. "
target: MedNets, Inc.
MedNets, Inc. offers MedExplore, our medical professional and patient Healthcare Information Directory, through our web site. We have gathered over 20,000 healthcare links in our directory, creating the source to the finest medical information on the Internet.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2007 via PR Newswire

ConnectivHealth, acquired Relegent

synopsis: ConnectivHealth today announced it has acquired Relegent, a Nashville, Tenn.--based provider of health care information to the hospital and education industries. Terms of the deal were not disclosed.
buyer parent: Chrysalis Ventures
buyer: ConnectivHealth
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and consumers. "
target: Relegent
Relegent is a leading health care information and marketing firm based in Nashville. Relegent owns and operates HealthTeacher, the leading K-12 online health curriculum. The company also exclusively markets Discovery Hospital content to hospitals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2007 via BusinessWire

MCF Corporation, acquired MedPanel, Inc.

synopsis: MCF Corporation has completed the acquisition of MedPanel, Inc., an online medical market intelligence firm. With the closing of the transaction, MedPanel, Inc. becomes Panel Intelligence, LLC, a wholly owned subsidiary of MCF Corporation.
buyer: MCF Corporation (MEM:$0.00)
MCF Corporation is a financial services holding company that provides investment research, capital markets services, corporate and venture services, investment banking, asset management and wealth management through its operating subsidiaries. "
target: MedPanel, Inc.
MedPanel provides online medical market intelligence to the life sciences industry through custom research and syndicated studies. Research services include study design, recruitment, programming, panel moderation, advanced data analysis and summaries.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2006 via PR Newswire

Medstat, acquired Solucient LLC

synopsis: The Thomson Corporation, a leading provider of information to professional customers worldwide, has completed the acquisition of Solucient, LLC, a healthcare information business. Terms of the deal were not disclosed.
buyer parent: The Thomson Corporation
buyer: Medstat
Thomson Medstat provides healthcare information services – databases, software applications, analytic consulting, and research services – to all sectors of the healthcare industry. "
target parent: The Nielsen Company, Inc.
target: Solucient LLC
Solucient is an information products company serving the healthcare industry. It is a leader in providing tools and vital insights that healthcare managers use to improve the performance of their organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/19/2006 via Company Press Release

Reed Elsevier plc, acquired Gold Standard Multimedia

synopsis: Elsevier, a world-leading healthcare and scientific publisher, announced today that it has entered into a definitive agreement to acquire the entire share capital of Gold Standard, Inc., a US-based developer of online clinical drug information products, services and solutions to the healthcare market.
buyer: Reed Elsevier plc (LSE:REL:$9,801.02)
Reed Elsevier is a world leading publisher and information provider. Operating in the scientific, medical, legal, risk and business-to-business sectors, Reed Elsevier provides high value and flexible information solutions to professional end users, with increasing emphasis on internet delivery. "
target: Gold Standard Multimedia
A privately-held company founded in 1993, Tampa, Florida-based Gold Standard Multimedia (GSM) is a leading developer of innovative medical education and drug information software, online services and e-learning solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/20/2005 via BNC Analysis

EBSCO Publishing, Inc., acquired DynaMed, LLC

synopsis: Expanding its presence in the medical arena, EBSCO Publishing (http://www.ebsco.com) announced the acquisition of DynaMed (http://www.dynamicmedical.com), an evidence-based clinical reference tool developed by a physician.
buyer parent: EBSCO Industries, Inc.
buyer: EBSCO Publishing, Inc.
EBSCO Publishing is the world's premier database aggregator, offering a suite of nearly 300 full-text and secondary research databases. EBSCO serves the content needs of all researchers: Academic, Medical, K-12, Public Library, Corporate, Government. "
target: DynaMed, LLC
DynaMed is a point-of-care reference resource designed to provide doctors and medical researchers with the best available evidence to support clinical decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2005 via PR Newswire

National Care Network, Inc., acquired Data Advantage Corporation

synopsis: National Care Network (NCN) has completed the acquisition of Data Advantage Corporation, a leading healthcare information company. The acquisition combines NCN's recognized cost control services with Data Advantage's strategic products and information.
buyer: National Care Network, Inc.
NCN is a privately owned healthcare cost management firm established in 1994 by medical claims experts. NCN is an industry leader in providing highly effective cost control services to all types of medical claims payors across the United States. NCN's proactive approach of on-going two way communica"
target: Data Advantage Corporation
Data Advantage Corporation is a healthcare information company. The company specializes in providing the healthcare, business and financial community a cost effective source for reliable and timely healthcare information products and services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
cancelled 11/17/2005 via BusinessWire

VNU nv, cancelled an acquisition of IMS Health Incorporated

synopsis: VNU NV announced it has agreed with IMS Health, Inc. to terminate the planned merger of the two companies. VNU said the two companies decided to call off their merger after shareholders claiming to represent nearly 50% of VNU's outstanding shares said they would not support the transaction under any circumstances.
buyer parent: Valcon Acquisition BV
buyer: VNU nv (NLSN:$6,465.00)
The Nielsen Company is world’s leading provider of marketing information, audience measurement, and business media products and services. Nielsen provides clients with the most complete view of their consumers and their markets. "
target: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations.
price ($mm)
$7,000
rev ($mm)
$1,569
EBITDA ($mm)
$517
EV / rev
4.5x
EV / EBITDA
13.5x
closed 3/14/2018 via PR Newswire

BioInformatics Inc., acquired IMV Ltd.

synopsis: BioInformatics Inc., the leading market research firm supporting the analytical instrumentation and life science industries, and owner of The Science Advisory Board, has acquired IMV Publishing, a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target: IMV Ltd.
IMV Publishing is a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets. IMV’s complete line of research reports provides decision makers with site-specific databases and comprehensive market reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2010 via Market Wire

TransUnion LLC, acquired MedData

synopsis: TransUnion announced it acquired MedData LLC. The Charlotte-based company provides healthcare insurance information and data solutions for hospitals, physician practices and major healthcare insurance companies. Financial terms of the deal were not disclosed.
buyer: TransUnion LLC (TRU:$2,696.90)
TransUnion is a global leader in credit and information management. The company creates advantages for millions of people around the world by gathering, analyzing and delivering information. For businesses TransUnion delivers comprehensive data and advanced analytics. "
target parent: AGData
target: MedData
MedData is the healthcare division of AGDATA, L.P. MedData was formed to apply and use state-of-the-art database and real-time transaction processing technology for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2013 via PR Newswire

Wolters Kluwer Health, acquired Health Language Inc.

synopsis: Wolters Kluwer Health, a leading provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy, announced that it has completed the acquisition of Health Language, Inc., a leader in the fast-growing Medical Terminology Management (MTM) market.
buyer parent: Wolters Kluwer NV
buyer: Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Its customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. "
target: Health Language Inc.
Health Language, Inc. specializes in the development, delivery and marketing of software that reduces the complexity of incorporating medical vocabulary and coding standards into healthcare information technology (HCIT) applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2008 via BusinessWire

Health Grades, Inc., acquired Adviware Pty. Ltd.

synopsis: Health Grades, Inc., the leading healthcare ratings company, announces the acquisition of WrongDiagnosis.com, a highly trafficked health information and community Web site. WrongDiagnosis.com was owned by Adviware Pty. Ltd., a privately held company based in Australia.
buyer: Health Grades, Inc. (HGRD:$58.17)
Health Grades, Inc. is the leading healthcare ratings organization, providing ratings and profiles of hospitals, nursing homes and physicians. Millions of patients and many of the nation’s largest employers, health plans and hospitals rely on HealthGrades’ independent ratings and advisory services. "
target: Adviware Pty. Ltd.
Adviware Pty. Ltd owns and operats WrongDiagnosis.com,which includes symptoms, diagnosis and treatment information including a database of statistics and cross-referenced medical information, tools and community forums covering more than 11,000 conditions and treatments.
price ($mm)[EV]
$6.24 [$4.41]
rev ($mm)
$2
EBITDA ($mm)
$1
EV / rev
3.9x
EV / EBITDA
7.2x
closed 4/11/2006 via PR Newswire

Workplace Options, acquired HelpHorizons.com, Inc.

synopsis: Workplace Options, the largest provider of work-life employee benefits in America, today announced the acquisition of HelpHorizons.com, Inc., the country's leading provider of practice management and connectivity solutions for mental health professionals and behavioral health organizations.
buyer: Workplace Options
Workplace Options (WPO) is America's largest provider of work-life services and software that help EAPs and other third-parties run their business more profitably and efficiently. "
target: HelpHorizons.com, Inc.
Dedicated to providing innovative services and information to consumers and mental health professionals. We offer the largest mental health professional referral database online today and technology that supports secure, private e-counseling via e-mail, chat rooms, or videoconferencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2013 via PR Web

Healthcare Data Solutions, acquired StratCenter

synopsis: Healthcare Data Solutions, a leading provider of healthcare databases, compliance and business intelligence services, announced the acquisition of StratCenter®, an established leader, delivering the most comprehensive provider facility databases and sales solutions available to the supply chain.
buyer: Healthcare Data Solutions
Healthcare Data Solutions is a leading healthcare information services company focused on building and maintaining the most accurate, compliance-grade data on Physicians, Dentists, Nurse Practitioners and other Healthcare Providers, as well as Pharmacies and Hospitals. "
target: StratCenter
StratCenter was founded in 2002 to provide the healthcare industry with a single point of access to the latest industry news, and to the most comprehensive sets of public and privately-held data on hospitals, IDNs, GPOs, and provider groups.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via BusinessWire

Press Ganey Associates, Inc., acquired Strategic Management Decisions

synopsis: Press Ganey has announced its acquisition of Strategic Management Decisions (SMD), a leading health care HR consulting and predictive analytics company. SMD’s proprietary technology enables health systems to optimize their talent acquisition and talent management efforts and realize measurable improvements in key HR performance metrics.
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement. "
target: Strategic Management Decisions
Strategic Management Decisions (SMD) is a leading health care HR consulting and predictive analytics company. SMD’s proprietary technology enables health systems to optimize their talent acquisition and talent management efforts and realize measurable improvements in key HR performance metrics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like AlphaImpactRx, Inc


read more

AlphaImpactRx, Inc

ImpactRx, Inc.

NHiS Ltd

TargetRx, Inc.

Dymaxium, Inc.

Vidal Group

MedicalDirector

Avalere Health LLC

Decision Resources Group

Edital

Prous Science

Infinata, Inc.

MeCompany

Pharmaspectra

AltaVoice

RJ Health Systems

SpringerProtocols

Humedica

iHealthEcon

Epidemico

read more

AlphaImpactRx, Inc

Source Healthcare Analytics, LLC

AlphaDetail, Inc.

TargetRx, Inc.

ImpactRx, Inc.

read more

Linguamatics Limited

Encore Health Resources

Privacy Analytics

Quintiles Transnational Corp.

Dimensions Healthcare, LLC

AlphaImpactRx, Inc

IASIST, S.A.

Dataline Software

Cegedim

Forcea

Pygargus

Diversinet Corp.

Incential Software, Inc.

360 Vantage

Semantelli

Appature

TTC LLC

PharmaDeals Ltd.

DecisionView, Inc.

PharmARC Analytic Solutions Pvt. Ltd.

read more

AlphaImpactRx, Inc

IMS Health Incorporated

Heart One Global Research

Clinical Practice Model Resource Center, Inc.

MedNets, Inc.

Relegent

MedPanel, Inc.

Solucient LLC

Gold Standard Multimedia

DynaMed, LLC

Data Advantage Corporation

IMS Health Incorporated

IMV Ltd.

MedData

Health Language Inc.

Adviware Pty. Ltd.

HelpHorizons.com, Inc.

StratCenter

Strategic Management Decisions

Tri Stat

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2019
rev ($mm)
$964.58
EBITDA ($mm)
$154.61
EBIT ($mm)
($47.97)
Net Income ($mm)
Employees
4515
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch
Ticker: OTCPK:NBGV
 
 
 
 
 
 
 
 
NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc. is a US public company which provides business consulting services to companies operating within the legal medical cannabis and hemp related industries.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($4.16)
Net Income ($mm)
Employees
14
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: CNSX:TCAN
 
 
 
 
 
 
 
 
TransCanna
TransCanna
TransCanna specializes in assisting cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. They offer our services throughout every aspect of the ecosystem; from branding and design, to transportation and distribution, to marketing and sales.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($1.66)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker: TDOC
 
 
 
 
 
 
 
 
TelaDoc, Inc.
TelaDoc, Inc.
Teladoc is the nation’s first and largest telehealth provider with more than 6 million members nationwide. Teladoc enhances access to affordable, high-quality medical care for adults and children via videoconferencing or telephone consultations.
year
2020
rev ($mm)
$716.29
EBITDA ($mm)
($8.58)
EBIT ($mm)
($53.74)
Net Income ($mm)
Employees
2727
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch